CVS HEALTH CorpCVS

NYSEConsumer EssentialsRetail-Drug Stores and Proprietary Stores
Price (close)
$89.13
Market cap
$113.9B
P/E
23.3x
Revenue (TTM)
$415.1B
Net income
$4.9B
Dividend yield
2.98%
1-year total return
23.3%
Net margin
1.2%
Revenue growth
7.4%
Debt / equity
0.77x

What CVS HEALTH Corp does.

CVS Health Corporation, together with its subsidiaries (collectively, “CVS Health,” the “Company,” “we,” “our” or “us”), is a leading health solutions company building a world of health around every consumer it serves and connecting care so that it works for people wherever they are. As of December 31, 2025, we had approximately 9,000 retail locations, more than 1,000 walk-in and primary care medical clinics and a leading pharmacy benefits manager with approximately 87 million plan members and expanding specialty pharmacy solutions. We serve an estimated more than 37 million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan (“PDP”). We are creating new sources of value through our integrated model allowing us to expand into personalized, technology driven care delivery and health services, increasing access to quality care, delivering better health outcomes and lowering overall health care costs.

The Company has four reportable segments: Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$268.7B$292.1B$322.5B$357.8B$372.8B$402.1B
Net income$7.2B$8.0B$4.3B$8.3B$4.6B$1.8B
Free cash flow$13.4B$15.7B$13.4B$10.4B$6.3B$7.8B

More on CVS.

Figures from CVS HEALTH Corp's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.